Contract award notice

Information

Published

Date of dispatch of this notice: 17/10/2022

External Reference: 2022-227198

TED Reference: 2022/S 204-578834

Contract award notice

[NoticeContractAward]

[NoticeContractAwardSub]

[Directive201424]

[Section1]: [Ca]

I.1)

[NameAddressContact]

National Institute for Bioprocessing Research & Training (NIBRT)
IE6433711D
Fosters Avenue, Mount Merrion, Blackrock
Dublin
Co. Dublin
IE
[Contactpoint]: Karl Kelly
[AddressPhone]: +353 12158100
[AddressEmail]: karl.kelly@nibrt.ie
[Nutscode]:  IE061 -  Dublin
[Internets]:
[UrlGeneral]: www.nibrt.ie

I.4)

[CaType]

[MaintypePublicbody]
I.5)

[Mainactivity]

[MainactivEducation]

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

A single cell platform for T-Cell therapy development
[Fileref]:  PR22-013
II.1.2)

[CpvMain]

38000000  - 
II.1.3)

[TypeContract]

[Supplies]
II.1.4)

[DescrShort]

NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of assays using single cells to enable exploration of cell therapy features, including but not limited to, screening of chimeric antigen receptor T cell constructs, discovery of T cell receptors or antigens, or exploration of regulatory T cell functions. The instrumental capabilities will be used by NIBRT as part of their current expansion and diversification to support all aspects of advanced therapy development and manufacture. The proposed instrument will be used to further our understanding of T cell immunotherapies through exploration of their phenotype, function and genotype.
II.1.6)

[LotsInfo]

[DivisionLots]: [No]
II.1.7)

[ValueTotal]

[ValueExclVat]:  481121.00  EUR
II.2)

[Description]

II.2.2)

[CpvAdditional]

38000000  - 
II.2.3)

[PlacePerformance]

[Nutscode]:  IE061 -  Dublin
[MainsiteplaceWorksDelivery]:  
National Institute For Bioprocessing Research and Training (NIBRT), Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin
II.2.4)

[DescrProcurement]

NIBRT is looking to procure an instrument for cell therapy development applications. The desired platform is one that supports the rapid development of assays using single cells to enable exploration of cell therapy features, including but not limited to, screening of chimeric antigen receptor T cell constructs, discovery of T cell receptors or antigens, or exploration of regulatory T cell functions. The instrumental capabilities will be used by NIBRT as part of their current expansion and diversification to support all aspects of advanced therapy development and manufacture. The proposed instrument will be used to further our understanding of T cell immunotherapies through exploration of their phenotype, function and genotype.
II.2.5)

[AwardCriteria]

[AwardCriteriaBelow]
[AwardCriterionQuality]  -  [AwardCriterionName]:  Product Quality and Fitness for Purpose  /  [Weighting]:  40
[AwardCriterionQuality]  -  [AwardCriterionName]:  Training Services  /  [Weighting]:  20
[AwardCriterionQuality]  -  [AwardCriterionName]:  Warranty Services  /  [Weighting]:  10
[AwardCriterionQuality]  -  [AwardCriterionName]:  Technical Support and Maintenance Services  /  [Weighting]:  15
[Price]  -  [Weighting]:  15
II.2.11)

[OptionsInfo]

[Options]: [No]
II.2.13)

[EuProgrInfo]

[EuProgrRelated]: [No]

[Section4]: [Procedure]

IV.1)

[Description]

IV.1.1)

[TypeProcedure]

[ProctypeOpen]
IV.1.8)

[GpaInfo]

[GpaCovered] : [Yes]
IV.2)

[InfoAdmin]

IV.2.1)

[PubPrevious]

[NumberOj]: 2022/S 105-292961

[Section5]: [AwardOfContract]

[ContractNumber]: 1

[TitleContract]: A single cell platform for T-Cell therapy development

[AwardConfirm]: [Yes]
V.2)

[AwardOfContract]

V.2.1)

[DateAward]

30/06/2022
V.2.2)

[AwardOffersInfo]

[OffersReceived]:  1
[OffersReceivedElectronic]:  1
[AwardedGroup] :  [No]
V.2.3)

[AwardedToName]

Berkeley Lights
377130692
5858 Horton Street. Suite 320
Emeryville
California
US
[AddressPhone]: +44 7377130212
[Nutscode]:  US -  United States

[AwardedSme] : [No]
V.2.4)

[ValueContractInfo] ([ExclVat])

[ValueTotalFinal]:  481121.00  EUR

[Section6]: [InfoComplement]

VI.4)

[AppealsProcedure]

VI.4.1)

[AppealsBody]

NIBRT
Fosters Avenue
Dublin
A94 X099
IE
[AddressEmail]: karl.kelly@nibrt.ie